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1. Introduction 
When vertebrate skeletal muscle is electrically 
stimulated under anoxic conditions, the glycolytic rate 
increases about IOO-fold in a manner directly propor- 
tional to the stimulation frequency, and it can increase 
up to 600-fold during tetanus [ 1,2] . Phosphofructoki- 
nase (EC 2.7.1 .11) undoubtedly plays a pivotal role in 
this extreme swing from a low to a high rate of glycolysis, 
and because the percent activation required during 
intense muscle work is so large, it is clear that this 
enzyme’s regulatory properties must be geared to allow 
for essentially ‘complete on-complete off catalytic 
behaviour [3]. How this may occur is not yet clear 
because the concentration of no single regulatory meta- 
bolite thus far studied falls or rises by a large enough 
factor to account for phosphofructokinase activation 
[ 1,2] . One possible mechanism of activation calls for 
synergistic effects by various metabolites [4,5]. 
Another possibility calls for mechanisms that amplify 
the small concentration changes in ATP** and AMP. 
A third possibility for phosphofructokinase regulation 
is the depletion of creatine phosphate known to occur 
in actively working muscle [6]. 
Creatine phosphate displays a number of characteris- 
tics that warrant serious consideration in regard to 
glycolytic control. During large (1 OO-fold) glycolytic 
activation in anoxic muscle, creatine phosphate con- 
* Present address: Department of Zoology, Duke University, 
Durham, North Carolina 27706, USA. 
** Abbreviations used: ATP, ADP, AMP, adenosine tri-, di-, 
mono-phosphate; Pi, inorganic phosphate; G6P, glucosed- 
phosphate; F6P, fructose-6-phosphate; CrP, creatine 
phosphate. 
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centrations drop from about 30 mM to 1 mM [2 ] ; at 
the same time, the concentration changes of other 
potentially important regulatory metabolites are very 
modest. ATP levels drop from 7.2 mM by only 
15-3070; ADP concentrations increase from about 
2.3 mM to 5.0 mM; AMP levels rise from 0.4 to 0.8 
mM; inorganic phosphate levels rise from about 4 to 
8 mM [l] . Because both the percentage change and the 
absolute change in creatine phosphate concentrations 
far surpass those of other regulatory metabolites, any 
effect on a key enzyme such as phosphofructokinase 
would be reflected in large changes in glycolytic rate. 
Other investigators have postulated a role for creatine 
phosphate in glycolytic activation in relation to its 
inhibitory effects on glyceraldehyde-3-phosphate 
dehydrogenase [7] and pyruvate kinase [8]. However, 
no attempts have been made to: a) look at the effect 
of creatine phosphate on the kinetic parameters of 
phosphofructokinase, or, b) quantitate the physiological 
importance of the creatine phosphate inhibition by 
evaluating its effects in concert with other known 
effecters of the enzyme. For this reason, and because 
creatine phosphate plays an important role in phosphe 
fructokinase control in the diving turtle [9] , we were 
prompted to examine its effects on mammalian muscle 
phosphofructokinase. 
We have found creatine phosphate inhibits muscle 
phosphofructokinase in a manner competitive with 
both substrates. The inhibition can be fully reversed 
with adenosine monophosphate and inorganic phosphate. 
This regulatory effect, in concert with known concen- 
tration changes in several key metabolites, can account 
for the ‘complete off-complete on’ catalytic behaviour 
that seems to occur at this enzyme step during activation 
of muscle glycolysis. 
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2. Materials and methods 
Crystalline rabbit muscle reagents, phosphofructo- 
kinase, and coupling enzymes were obtained through 
Sigma Chemical Co., St. Louis. The phosphofructokinase 
was supplied as a suspension containing 1.3 M 
(NH,)2 SO4, 50 mM glycerophosphate, 4 mM adenosine 
phosphate, and 1 mM dithiothreitol. The enzyme was 
diluted 40-fold prior to assay in a mixture of 50 mM 
TrisHCl (pH 8.0), 2 mM EDTA, 50 mM P-mercap- 
toethanol and 2 mM Mg2 +. Under these conditions the 
enzyme is stable for several hours. In all experiments 
5 ~1 of the diluted enzyme was used to start the reac- 
tion. 
Standard assays for the determination of kinetic 
constants contained the following in a final vol of 1 ml: 
50 mM Tris-HCl (pH 7.0), Mg”, K’, fructosed- 
phosphate, ATP, P-enolpyruvate, NADH, and excess 
dialyzed Sigma pyruvate kinase and lactate dehydroge- 
nase. 
Assays measuring the effects of simulated in vivo 
conditions contained in a final vol of 3 ml: 50 mM 
Tris-HCl (pH 7.2), various substrates and effecters 
as listed in table 1, NADH and excess dialyzed Sigma 
alphaglycerophosphate dehydrogenase, triosephosphate 
isomerase, and aldolase. All assays were performed at 
25°C. 
The following experiments were performed to rule 
out indirect effects of creatine phosphate: 
(1) In both assay methods, creatine phosphate may 
inhibit one of the coupling enzymes and give rise to 
apparent phosphofructokinase inhibition. The fructose- 
diphosphate sampling method [lo] was used to 
measure phosphofructokinase activity in the presence 
and absence of creatine phosphate. These studies 
showed that under the assay conditions employed the 
effect of creatine phosphate is on phosphofructokinase 
alone. 
(2) If the commercial enzymes contain significant 
activities of creatine phosphokinase, this will have the 
effect of raising the ATP concentration (due to ADP 
contamination of reagents). The levels of creatine 
phosphokinase was measured and found to be 0.0003 
units per min per assay tube. This very low activity 
would have no significant effects on the ATP concen- 
trations over the assay time periods used. 
3. Results and discussion 
In agreement with previous studies [9,1 l] , we 
found creatine phosphate to be a potent inhibitor of 
rabbit muscle phosphofructokinase. The inhibition is 
competitive with respect to both substrates, fructose- 
6-phosphate and ATP. Dixon plots of l/velocity vs. 
creatine phosphate concentration indicate an inhibition 
constant of about 13 mM with respect to fructose-6- 
phosphate. The effect of creatine phosphate plus a 
number of other phosphofructokinase modulators is 
shown in fig. 1. In common with other phosphofructo- 
kinases [ 121, fructose-6-phosphate saturation curves 
are strongly sigmoidal. Creatine phosphate greatly 
decreases the apparent enzyme-substrate affinity but 
has essentially no effect on the maximum velocity of 
the reaction. Most significantly, all creatine phosphate 
inhibitory effects can be fully reversed by AMP and 
Table 1 
An attempt to assess the relative activities of phosphofructokinase under conditions simulating 
muscle at rest and muscle at work 
Rate relative Muscle metabolite Physiological 
to control’ concentrations’, mM state of muscle’ 
CrP ATP ADP AMP Pi G6P F6P NH: Mg'+ K+ 
1 30 7.2 3.3 0.4 4.0 0.2 0.05 0.3 11 100 resting 
100 30 4.0 4.0 0.8 8.0 1.9 1.0 1.0 11 100 creatine phosphate 
inhibited 
200 1 4.0 4.0 0.8 8.0 1.9 1.0 1.0 11 100 contracting 
’ Control: The rate of reaction (0.0021 O.D.,,, /min) with the concentration of effecters and substrates observed in resting muscle. 
’ These values taken from [ 2,5 ] . 
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Fig. 1. Effects of metabolites on the velocity (v) of rabbit 
skeletal muscle phosphofructokinase at pH 7.0. Reaction 
conditions: 50 mM Tris-HCl buffer, 5 mM Mg’+, 100 mM K’, 
0.15 mM NADH, varying concentrations of fructose-6- 
phosphate, 1 mM P-enolpyruvate, excess Sigma dialyzed 
pyruvate kinase and lactate dehydrogenase. The symbols re- 
present the following conditions: (0) control with 0.5 mM 
ATP; (a) control plus 1 mM ATP; (0) control plus 20 mM 
creatine phosphate; (A) control plus 1 mM ATP and 20 mM 
creatine phosphate; (0) control plus 0.5 mM AMP with 1 mM 
ATP and 20 mM creatine phosphate; ((8) control plus 0.5 mM 
AMP with 1 mM ATP or control plus 0.5 mM AMP with 
20 mM creatine phosphate; (m) control plus 7 mM inorganic 
phosphate and 20 mM creatine phosphate. 
inorganic phosphate, but the latter is clearly more 
effective. Thus in the presence of both inorganic 
phosphate and creatine phosphate, the substrate 
saturation curve becomes hyperbolic and there is a 
large (40-fold) increase in the apparent enzyme-sub- 
strate affinity as well as in the maximum velocity of 
the reaction. The combined regulatory effects of these 
metabolites raises the potential for sensitive control of 
this key step in glycolysis, but just how large might 
the role of creatine phosphate be? 
To answer the latter question we measured the 
activity of muscle phosphofructokinase under condi- 
tions simulating muscle at rest and muscle at work 
(see [4,5] for similar attempts by others). From these 
experiments (table l), it is clear that the summed 
effects of increasing substrate availability, increasing 
positive modulator concentrations, and decreasing ATP 
lead to about a loo-fold activation of phosphofructo- 
kinase. When creatine phosphate concentrations are 
also dropped (from 30 to 1 mM), the overall phospho- 
fructokinase activity rises by about 200-fold (table 1). 
The magnitude of these effects therefore would appear 
to be large enough to account for the known percen- 
tage changes that occur in glycolysis during intense 
muscle work [ 1,2] , but they would not appear to be 
large enough to account for the level of glycolytic 
activation noted during extreme situations such as 
tetanus. 
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